Lansoprazole Capsule, Delayed Release
Product Images NDC 50090-5180

4 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 50090-5180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole-figure-1 (Lansoprazole Figure 1)

Lansoprazole-figure-1 (Lansoprazole Figure 1)
A line graph showing mean severity of day heartburn over study days for evaluable patients treated with placebo, lansoprazole 15 mg QD, and lansoprazole 30 mg QD. The vertical axis represents mean severity levels from 0 (none) to 3 (severe), and the horizontal axis represents days from the start of treatment, ranging from -5 to 60 days. Lansoprazole treatments show reduced severity compared to placebo.*
FDA Label Image

Lansoprazole-figure-2 (Lansoprazole Figure 2)

Lansoprazole-figure-2 (Lansoprazole Figure 2)
A line graph showing the mean severity of night heartburn by study day for evaluable patients over approximately 60 days from the start of treatment. The y-axis measures severity from 0 (none) to 3 (severe). Three lines compare placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily, illustrating reduced heartburn severity over time for both Lansoprazole doses compared to placebo.*
FDA Label Image

Lansoprazole-str (Lansoprazole Str)

Lansoprazole-str (Lansoprazole Str)
Chemical structure of the active ingredient Lansoprazole, showing its molecular arrangement with benzene rings, sulfinyl, and substituted pyridine groups.*
FDA Label Image

Label Image (Lbl500905180)

Label Image (Lbl500905180)
Packaging label for Lansoprazole 30 mg delayed-release capsules by A-S Medication Solutions. The label specifies the capsule as peach and black, containing Lansoprazole USP 30 mg as an enteric-coated granule. It includes the NDC 50090-5180-0 and packaging details indicating 30 capsules in the package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.